藥物成份

共有 21645 個藥物成份

CARYOPHILLI OIL

• 關聯藥證數量: 1

CARYOPHYLLUS TINCTURE

• 關聯藥證數量: 1

CARZENIDE SODIUM(O-BENZOIC ACID SULFINID-SODIUM)

• 關聯藥證數量: 1

CASCARA SAGRADA

• 關聯藥證數量: 1

CASEIN DISODIUM GLYCEROPHOSPHATE

• 關聯藥證數量: 1

CASEIN FORMALDEHYDE

• 關聯藥證數量: 1

CASEIN HCL

• 關聯藥證數量: 1

CASSIA CINNAMON

• 關聯藥證數量: 1

CASTOR OIL HYDROGENATED POLYOXYETHYLENE ETHER

• 關聯藥證數量: 1

CASTOR OIL POLYOXYETHYLATED

• 關聯藥證數量: 1

CASTOR OIL SOAP

• 關聯藥證數量: 1

CATIONIC SURFACTANT………………0.34%SODIUM CHLORIDE…………………..0.535%TRIS-BUFFER…………………………..0.133%

• 關聯藥證數量: 1

CCTNI:Wellsa Ingredient Quantityb Source\n1 Alkaline phosphatase conjugated to anti-cardiac troponin IFab’ Buffer c Calf intestine (enzyme) Mouse (monoclonal antibody)\n2 Dendrimer linked Cardiac troponin Iantibody c Mouse IgG monoclonal\n3 \n4 4-methylumbelliferyl phosphate Diethanolamine buffer, Na azide 1 mmol/L \n5 Sample Well \nCCTNI-CR: The cTnI CalPak I a frozen liquid containing native, human troponin complex, in a normal human serum base and 0.09% sodium azide.CCTNI-D: The cTnI DilPak contains phosphate buffer with preservatives, including 0.09% sodium azide.

• 關聯藥證數量: 1

CD19 (4G7): the CD19 antibody is composed of mouse IgG1 heavy chains and kappa light chains. The monoclonal antibody is supplied as 50 μg purified immunoglobulin in 2.0 ml (25 μg/ml) of phosphate-buffered saline (PBS). The FITC conjugate is supplied as 50 μg in 2.0 ml (25 μg/ml) of PBS. PBS contains gelatin and 0.1% sodium azide. \nAnti-Kappa/Anti-Lambda: anti-Kappa and anti-Lambda are each composed of mouse IgG1 heavy chains and kappa light chains. The Simultest reagent is supplied as a combination of anti-kappa FITC and anti-lambda PE in 1.0 ml of phosphate-buffered saline (PBS). Twenty microliters (20 μl) of the conjugated antibody stain 106 peripheral blood mononuclear cells (PBMCS). PBS contains gelatin and 0.1% sodium azide.\nLambda F(ab’)2/CD19: CD19 is composed of mouse IgG1 heavy chains and kappa light chains. The Simultest reagent is supplied as a combination of Lambda F(ab’)2 FITC and CD19 PE in 1.0 ml of phosphate-buffered saline (PBS). Twenty microliters (20 μl) of the conjugated antibody stain 1

• 關聯藥證數量: 1

CD3 (IgG1)-RD1: The concentration of nonantibody reagents in 0.5 mL (1 vial) is 0.2% BSA, 0.01 M potassium phosphate, 0.15M NaCl, 0.1% NaN3, and stabilizers.

• 關聯藥證數量: 1

CDDMR TestPak:Alkaline phosphateconjugated to anti-D-dimer Fab’,ACE Buffer, Na azide,Dendrimer linkedD-dimer antibody,Tris buffer, 4-methylumbelliferyl phosphateDiethanolamine buffer, CDDMR-C: The DDMR CalPak contains D-dimer in a buffered bovine protein matrix with stabilizers and＜0.1% sodium azide.CMMER-D: The DDMR DilPak contains liquid buffered bovine protein matrix with stabilizers and＜0.1% sodium azide.

• 關聯藥證數量: 1

CEA Ab-Coated Tubes : Polystyrene tubes coated with anti-CEA murine monoclonal antibodies and packaged in zip-lock bags.\n125I CEA Ab : Iodinated anti-CEA goat polyclonal antibody in liquid form, with preservative. \nCEA Calibrators : labeled A through G, of lyophilized CEA calibrators in a CEA-free human-serum matrix, with preservatives.

• 關聯藥證數量: 1

CEA Diluent：\nBovine albumin

• 關聯藥證數量: 1

CEA control and calibrator：\nBovine albumin + human CEA

• 關聯藥證數量: 1

CEDAR LEAF OIL

• 關聯藥證數量: 1

CEDAR WOOD OIL

• 關聯藥證數量: 1

CEDEPAL TD-403

• 關聯藥證數量: 1

CEFACLOR MONOHYDRATE

• 關聯藥證數量: 1

CEFATRIZINE

• 關聯藥證數量: 1

CEFAZOLIN ACID

• 關聯藥證數量: 1

CEFAZOLIN SODIUM HAS A POTENCY EQUIVALENT TO NOT LESS THAN 89.1% AND NOT MORE THAN 110.1% OF C14H13NaN8O4S3, CALCULATED ON THE ANHYDROUS BASIS.

• 關聯藥證數量: 1

CEFMENOXIME (HEMIHYDROCHLORIDE)

• 關聯藥證數量: 1

CEFOTETAN

• 關聯藥證數量: 1

CEFOXITIN SODIUM STERILE contains 927ug~970ug of Cefoxitin (C16H17N3O7,S2) per mg, calculated on the anhydrous basis and acetone-and methanol-free basis.

• 關聯藥證數量: 1

CEFPODOXIME PROXETIL

• 關聯藥證數量: 1

CEFPROZIL ANHYDROUS

• 關聯藥證數量: 1

CEFPROZIL contains not less than 900ug and not more than 1050 ug of C18H19N3O5S per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

CEFRADINE-L-ARGININE

• 關聯藥證數量: 1

CEFSULODIN (SODIUM)

• 關聯藥證數量: 1

CEFTIBUTEN

• 關聯藥證數量: 1

CEFUROXIME SODIUM STERILE contains 855ug~1000ug of (C16H15N4NaO8S)per mg, calculated on the anhydrous basis.

• 關聯藥證數量: 1

CELL-DYN 18 Plus Control are in vitro diagnostic products that may contain any or all of the following:\nstabilized human or mammalian red blood cells, human, mammalian or simulated white blood cells and a platelet component in a preservative medium. \n

• 關聯藥證數量: 1

CELL-DYN 1800 Analyzer\nFront Panel\nLeft Side Panel\nRight Side Panel\nRear Panel\nComputer Section

• 關聯藥證數量: 1

CELL-DYN 26 Plus Control is an in vitro diagnostic reagent containing stabilized, lysable simulated platelet components, human red cells, and fixed human white cells (nonreactive to FDA licensed tests for HBsAg, anti HCV, Syphilis, anti HIV-1/HIV-2, HIV-1 Ag or HIV-1 RNA, and HCV RNA.) suspended in a medium containing preservatives.

• 關聯藥證數量: 1

CELLASE

• 關聯藥證數量: 1

CELLULOSE CRYSTALLINE (eq to CRYSTALLINE CELLULOSE)

• 關聯藥證數量: 1

CELLULOSE FIBROUS

• 關聯藥證數量: 1

CELLULOSE SPECIAL GRADE

• 關聯藥證數量: 1

CELLULOSE WOOD

• 關聯藥證數量: 1

CELLULOSIN

• 關聯藥證數量: 1

CENTELLA ASIATICA TRITERPENES

• 關聯藥證數量: 1

CEPHADROXIL

• 關聯藥證數量: 1

CEPHARANTIN

• 關聯藥證數量: 1

CEREBRI EXTRATE

• 關聯藥證數量: 1

CEREBROLYSIN CONCENTRATE

• 關聯藥證數量: 1

CERIUM NITRATE 6H2O

• 關聯藥證數量: 1

CERVI CORNU

• 關聯藥證數量: 1

CERVUS SIKA

• 關聯藥證數量: 1

CER抗體(山羊抗體) 5ML防蒸發蓋 2疊氮化鈉(作為防腐劑) <0.1%(重量/重量)

• 關聯藥證數量: 1

CER試劑筒(山羊多克隆抗血漿藍包漿素蛋白抗體 3.9ML) 防蒸發蓋 2CER試劑條碼卡 1疊氮化鈉(作為防腐劑) <0.1%(重量/重量)

• 關聯藥證數量: 1

CETILPIRIDINIUM CHLORIDE

• 關聯藥證數量: 1

CETOMACROGOL EMULSIFYING WAX

• 關聯藥證數量: 1

CETOTIAMINE

• 關聯藥證數量: 1

CETRIMONIUM

• 關聯藥證數量: 1

CETRIMONIUM CHLORIDE

• 關聯藥證數量: 1

CETUXIMAB, CHIMERIC ANTIBODY

• 關聯藥證數量: 1

CETYL DIMETHYL-ETHYL-AMMONIUM BROMIDE

• 關聯藥證數量: 1

CETYLPYRIDINIUM CHLORIDE MONOHYDRATE

• 關聯藥證數量: 1

CHAMOMILE

• 關聯藥證數量: 1

CHAMOMILLAE FLORES EXTRACT

• 關聯藥證數量: 1

CHARCOAL ACTIVATED (EQ TO ACTIVATED CHARCOAL)

• 關聯藥證數量: 1

CHARCOAL VEGET

• 關聯藥證數量: 1

CHELIDONIUM HERBA EXTRACT

• 關聯藥證數量: 1

CHEM II Calibrators is an aqueous solution of pure magnesium dissolved in a dilute solution of HCl, reagent grade potassium dihydrogen phosphate (KH2PO4), and reagent grade glycerol (C3H8O3).

• 關聯藥證數量: 1

CHERRY MARASCHINO

• 關聯藥證數量: 1

CHERRY PIT FLAVORIMITATION

• 關聯藥證數量: 1

CHIDII RHIZOMA EXTRACT

• 關聯藥證數量: 1

CHIMAPHILA UMBELLATA ALCOHOLIC EXTRACT

• 關聯藥證數量: 1

CHLORAMBUCIL

• 關聯藥證數量: 1

CHLORAMINE T

• 關聯藥證數量: 1

CHLORAMPENICOL SODIUM SUCCINATE STERILE

• 關聯藥證數量: 1

CHLORAMPHENICOL (GLYCINATE SULFATE)

• 關聯藥證數量: 1

CHLORAMPHENICOL (SUCCINATE)

• 關聯藥證數量: 1

CHLORAMPHENICOL CONTAINS NOT LESS THAN 97.0% AND NOT MORE THAN 103.0% OF C11H12CL2N2O5.

• 關聯藥證數量: 1

CHLORAMPHENICOL D-

• 關聯藥證數量: 1

CHLORAMPHENICOL MONOSUCCINATE

• 關聯藥證數量: 1

CHLORAMPHENICOL SODIUM SUCCINATE STEARATE

• 關聯藥證數量: 1

CHLORHEXIDINE 2HCL (EQ TO CHLORHEXIDINE DIHYDROCHLORIDE)

• 關聯藥證數量: 1

CHLORHEXIDINE GLUCONATE 20% SOLUTION contains not less than 19.0% w/v and not more than 21.0% w/v of C22H30Cl2N10.2C6H12O7.

• 關聯藥證數量: 1

CHLORHEXIDINE GLUCONATE 20% SOLUTION contains not less than 19.0% w/v and not more than 21.0% w/v of C22H30Cl2N10‧2C6H12O7.

• 關聯藥證數量: 1

CHLORIDE (HYDROCHLORIDE)

• 關聯藥證數量: 1

CHLORINE ION

• 關聯藥證數量: 1

CHLORMADINONE ACETATE

• 關聯藥證數量: 1

CHLORMIDAZOLE HCL

• 關聯藥證數量: 1

CHLORMIDAZOLE HCL(HYDRATE)

• 關聯藥證數量: 1

CHLORO -5 -8 QUINOLINOL

• 關聯藥證數量: 1

CHLOROBUTANOL ANHYDROUS

• 關聯藥證數量: 1

CHLOROGUANIDE HCL

• 關聯藥證數量: 1

CHLOROPHYLL DERIVATIVES WATER SOLUBLE

• 關聯藥證數量: 1

CHLOROPHYLL EXTRACT FROM KUMAZASA

• 關聯藥證數量: 1

CHLOROPHYLL POTASSIUM COPPER

• 關聯藥證數量: 1

CHLOROPHYLL SODIUM

• 關聯藥證數量: 1

CHLOROPREDNISON ACETATE

• 關聯藥證數量: 1

CHLOROPROPIOPHENONE

• 關聯藥證數量: 1

CHLOROPROTHIXENE (CITRATE)

• 關聯藥證數量: 1